14-day Premium Trial Subscription Sign Up For FreeGet Free

Corbus Pharmaceuticals Holdings Stock Forecast NASDAQ:CRBP

Price Target and Analyst Ratings

Most Recent Rating

HC Wainwright is very positive about CRBP and gave it a "Buy" rating on October 08, 2020. The price target was changed from $6.00 to $3.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-03-16 Hold Reiterated by Oppenheimer $2.18
2020-10-08 Buy Target Lowered by HC Wainwright $1.23 $6.00 → $3.00
2020-09-09 Buy Target Lowered by HC Wainwright $2.44 $24.00 → $6.00
2020-09-08 Outperform - Market Perform Downgraded by Oppenheimer $2.23
2020-09-08 Outperform - Sector Perform Downgraded by Royal Bank of Canada $2.23 $22.00 → $3.00
2020-09-08 Buy - Hold Downgraded by Jefferies Financial Group $2.23 $18.00 → $2.50
2020-09-08 Buy - Neutral Downgraded by BTIG Research $2.23
2020-09-08 Buy - Neutral Downgraded by Roth Capital $2.23 $40.00 → $3.00
2020-08-07 Buy Reiterated by HC Wainwright $6.61 $24.00
2020-07-27 Buy Target Raised by Jefferies Financial Group $7.18 $17.00 → $18.00
2020-07-07 Buy Initiated by Roth Capital $8.03 $40.00
2020-06-29 Buy Reiterated by Oppenheimer $7.91 $28.00
2020-06-19 Buy Reiterated by Oppenheimer $7.68 $28.00
2020-06-16 Buy Initiated by BTIG Research $7.58 $22.00
2020-06-04 Buy Target Raised by Nomura Instinet $6.89 $12.00 → $32.00
2020-06-04 Buy Target Raised by Nomura $6.89 $12.00 → $32.00
2020-05-13 Buy Reiterated by Nomura $6.50 $12.00
2020-05-11 Buy Reiterated by Oppenheimer $6.64 $28.00

CRBP Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -40.60% during the next 3 months and, with a 90% probability hold a price between $0.57 and $0.75 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-20 $0.95 $1.10 $1.26
2021-09-21 $0.93 $1.09 $1.24
2021-09-22 $0.92 $1.08 $1.23
2021-09-23 $0.91 $1.06 $1.22
2021-09-24 $0.89 $1.05 $1.20
2021-09-27 $0.88 $1.03 $1.19
2021-09-28 $0.87 $1.02 $1.17
2021-09-29 $0.85 $1.01 $1.16
2021-09-30 $0.84 $0.99 $1.15
2021-10-01 $0.82 $0.98 $1.13
2021-10-04 $0.81 $0.96 $1.12
2021-10-05 $0.80 $0.95 $1.11
2021-10-06 $0.78 $0.94 $1.09
2021-10-07 $0.77 $0.92 $1.08
2021-10-08 $0.76 $0.91 $1.06
2021-10-11 $0.74 $0.90 $1.05
2021-10-12 $0.73 $0.88 $1.04
2021-10-13 $0.71 $0.87 $1.02
2021-10-14 $0.70 $0.85 $1.01
2021-10-15 $0.69 $0.84 $0.99
2021-10-18 $0.67 $0.83 $0.98
2021-10-19 $0.66 $0.81 $0.97
2021-10-20 $0.65 $0.80 $0.95
2021-10-21 $0.63 $0.79 $0.94
2021-10-22 $0.62 $0.77 $0.93
2021-10-25 $0.60 $0.76 $0.91
2021-10-26 $0.59 $0.74 $0.90
2021-10-27 $0.58 $0.73 $0.88
2021-10-28 $0.56 $0.72 $0.87
2021-10-29 $0.55 $0.70 $0.86

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. Its lead product candidate includes Resunab, a novel oral endocannabinoid-mimetic drug, which is in Phase 2 clinical trials for the treatment of cystic fibrosis, systemic sclerosis, and skin-predominant dermatomyositis diseases. The company is based in N... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT